PMGC Signs Deal to Buy 76% Stake in Arizona Manufacturer, Financial Terms Remain Undisclosed
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q1 2026 Results and Files Form 10-Q; Total Assets Reach Over $26.0 Million, Up 102% from Year-End 2025 and 193% Year-over-Year
PMGC Holdings Q4 EPS $(11.22) Up From $(243.76) YoY, Sales $681.994K
UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological Disorders
NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans
PMGC Holdings' Northstrive Biosciences Files New U.S. Patent Application Expanding Proprietary EL-22, Myostatin-Engineered Probiotic Technology, Into Human Pharmaceutical Applications
NorthStrive Defense Tech Acquires Patented GPS-Denied Autonomous Drone Navigation Technology Option, Built for Defense and Counter-Unmanned Aircraft Systems
PMGC Holdings' Subsidiary Obtains License Option Over Autonomous Positioning, Navigation For Unmanned Aircraft Systems, Drones
Univest Securities, LLC Announces a $40 Million Equity Line Facility for its Client PMGC Holdings, Inc. (NASDAQ: ELAB)
SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.
PMGC's Subsidiary Executes Agreement With California-Based Turbo-Jet Products
PMGC Holdings Raises $7.8M In Common Stock Sale To Streeterville Capital Under Equity Line Facility
PMGC Holdings, Inc. (Nasdaq: ELAB) Secures $40 Million Equity Purchase Facility Agreement: Announces Ability To Accelerate M&A Strategy Currently Focused on Acquiring Aerospace and Defense Manufacturing Companies
Why Is PMGC Holdings Stock Gaining Friday?
PMGC holdings secures $40 million equity facility to fund aerospace and defense acquisitions and accelerate M&A strategy
What's Going On With PMGC Holdings Stock?
NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences
ELAB stock has given up its prior gain. PMGC Holdings shares were trading higher after the company announced its subsidiary, NorthStrive Biosciences, transferred EL-32 Working Cell Bank to a U.S.-based third-party fermentation facility.
PMGC Holdings shares are trading higher after the company announced its subsidiary, NorthStrive Biosciences, transferred EL-32 Working Cell Bank to a U.S.-based third-party fermentation facility.
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.